{
  "id": "54f9b74306d9727f76000004",
  "type": "factoid",
  "question": "The drug JTV519 is derivative of which group of chemical compounds?",
  "ideal_answer": "The 1,4-benzothiazepine derivative JTV-519 is a new type of calcium ion channel modulator.JTV-519, which has potential use as an antiarrhythmic [285800]. The drug is a novel cardioprotectant derivative of 1,4-benzothiazepine for which phase I trials were completed in the third quarter of 1998",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/11429046",
    "http://www.ncbi.nlm.nih.gov/pubmed/11757794",
    "http://www.ncbi.nlm.nih.gov/pubmed/21989257",
    "http://www.ncbi.nlm.nih.gov/pubmed/10683355",
    "http://www.ncbi.nlm.nih.gov/pubmed/15073377",
    "http://www.ncbi.nlm.nih.gov/pubmed/12433661",
    "http://www.ncbi.nlm.nih.gov/pubmed/23349825",
    "http://www.ncbi.nlm.nih.gov/pubmed/17112502",
    "http://www.ncbi.nlm.nih.gov/pubmed/10789707",
    "http://www.ncbi.nlm.nih.gov/pubmed/22509897",
    "http://www.ncbi.nlm.nih.gov/pubmed/12551874",
    "http://www.ncbi.nlm.nih.gov/pubmed/12359358",
    "http://www.ncbi.nlm.nih.gov/pubmed/17313373",
    "http://www.ncbi.nlm.nih.gov/pubmed/10864882",
    "http://www.ncbi.nlm.nih.gov/pubmed/11101196"
  ],
  "snippets": [
    {
      "text": "In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca\u00b2\u207a leak.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22509897",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The 1,4-benzothiazepine derivative JTV519, and the more specific derivative S107 (2,3,4,5,-tetrahydro-7-methoxy-4-methyl-1,4-benzothiazepine), are thought to improve skeletal muscle function by stabilizing the RyR1-FKBP12 complex.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23349825",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "In this article, we synthesize derivatives of the channel activator 4-chloro-3-methyl phenol (4-CmC) and the 1,4-benzothiazepine channel inhibitor 4-[-3{1-(4-benzyl) piperidinyl}propionyl]-7-methoxy-2,3,4,5-tetrahydro-1,4-benzothiazepine (K201, JTV519) with enhanced electron donor properties.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21989257",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "K201 (JTV519), a benzothiazepine derivative, has been shown to possess anti-arrhythmic and cardioprotective properties, but the mechanism of its action is both complex and controversial.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/17313373",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "K201 (JTV519) is a 1,4-benzothiazepine derivative that exhibits a strong cardioprotective action and acts as a multiple-channel blocker, including as a K+ channel blocker.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/17112502",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "A derivative of 1,4-benzothiazepine (JTV519) increased the affinity of calstabin2 for RyR2, which stabilized the closed state of RyR2 and prevented the Ca2+ leak that triggers arrhythmias.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/15073377",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "We report that a new drug, the 1,4-benzothiazepine derivative JTV519, reverses this pathogenic process. JTV519 is known to have a protective effect against Ca2+ overload-induced myocardial injury.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/12551874",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "In conclusion, JTV519, a new 1,4-benzothiazepine derivative, corrected the defective channel gating in RyR (increase in both the rapid conformational change and the subsequent Ca(2+) release rate) in HF.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/12433661",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "A newly synthesized 1,4-benzothiazipine derivate, 4-[3-(4-benzylpiperidin-1-yl) propionyl]-7-methoxy-2,3,4,5-tetrahydro-1, 4-benzothiazepine monohydrochloride (JTV-519) was examined for its ability to reverse P-glycoprotein (P-gp) and multidrug resistance protein 1 (MRP1) mediated multidrug resistance (MDR) in K562/MDR and KB/MRP cells, respectively. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/12359358",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "JTV-519, which has potential use as an antiarrhythmic [285800]. The drug is a novel cardioprotectant derivative of 1,4-benzothiazepine for which phase I trials were completed in the third quarter of 1998",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/11757794",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The 1,4-benzothiazepine derivative JTV-519 is a new type of calcium ion channel modulator.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/11429046",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "A new 1,4-benzothiazepine derivative, JTV519 (JTV), has strong protective effects against isoproterenol-induced myocardial injury. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/11101196",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "A newly synthesized benzothiazepine derivative, JTV-519 (JT) has been reported to be cardioprotective.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/10864882",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Protective effect of JTV519, a new 1,4-benzothiazepine derivative, on prolonged myocardial preservation",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/10789707",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "A new 1,4-benzothiazepine derivative, JTV519, has a strong protective effect against Ca(2+) overload-induced myocardial injury.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/10683355",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": " We report that a new drug, the 1,4-benzothiazepine derivative JTV519, reverses this pathogenic process.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/12551874",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Protective effect of JTV519, a new 1,4-benzothiazepine derivative, on prolonged myocardial preservation.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/10789707",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "A new 1,4-benzothiazepine derivative, JTV519 (JTV), has strong protective effects against isoproterenol-induced myocardial injury.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/11101196",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "A new 1,4-benzothiazepine derivative, JTV519, has a strong protective effect against Ca(2+) overload-induced myocardial injury.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/10683355",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": " In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca?\u207a leak.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22509897",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The cardioprotective effects of a new 1,4-benzothiazepine derivative, JTV519, on ischemia/reperfusion-induced Ca2+ overload in isolated rat hearts.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/11101196",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "We report that a new drug, the 1,4-benzothiazepine derivative JTV519, reverses this pathogenic process",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/12551874",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [
    "http://www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&exact=Find+Exact+Term&term=chemicals_and_drugs_category",
    "http://www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&exact=Find+Exact+Term&term=D004339"
  ],
  "exact_answer": "1,4-benzothiazepine, benzothiazepine"
}